Publications by authors named "S Hauser"

Claim this Profile
R
Reply to "New Horizons for Multiple Sclerosis Therapy: 2025 and Beyond".
Joseph J Sabatino, Bruce A C Cree, Stephen L Hauser

Ann Neurol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Initial Prostate-Specific Membrane Antigen PET/CT Staging and Prostate-Specific Membrane Antigen-Targeted Biopsy on Treatment Decisions in Prostate Cancer: Results from the Phase 2 DEPROMP Trial.
Philipp Krausewitz, Markus Essler, Florian C Gaertner, Ulrike Attenberger, Julian A Luetkens, Stefan Hauser

J Nucl Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro Characterization of the Published Glypican-3-Targeting Peptide TJ12P2 Reveals a Lack of Specificity and Potency.
Eva-Maria Burger, Charlice Hill, Robert Wodtke, Kristof Zarschler, Markus Laube, Sandra Hauser

Pharmaceuticals (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Six-year safety and efficacy outcomes with first-line ofatumumab in recently diagnosed treatment-naive patients with relapsing multiple sclerosis.
Stephen L Hauser, Mark S Freedman, Jin Nakahara, David Paling, Jérôme de Seze

Mult Scler Relat Disord· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Implementation of Tumor Board Decisions: A Retrospective Single Center Observational Study in Germany.
Johanna Ernst, Katharina Alfter, Alexander Mustea, Andree Faridi, Tim Glowka, Stefan Hauser

In Vivo· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis